Penserra Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-20,160
Closed -$1.08M – 1353
2023
Q3
$1.08M Buy
20,160
+9,920
+97% +$529K 0.02% 344
2023
Q2
$551K Sell
10,240
-320
-3% -$17.2K 0.01% 495
2023
Q1
$574K Buy
10,560
+7,680
+267% +$374K 0.01% 471
2022
Q4
$139K Buy
2,880
+1,920
+200% +$84.3K ﹤0.01% 756
2022
Q3
$36K Buy
+960
New +$42.8K ﹤0.01% 845

Other funds holding SNY

Penserra Capital Management's SNY Position: Q4 2023 in Review

Penserra Capital Management sold out of Sanofi (SNY) in Q4 2023, closing a stake of 20,160 shares — an estimated $1.08M sold.

Penserra Capital Management first reported a position in SNY in Q3 2022 and held it in 5 quarters. The position peaked at $1.08M in Q3 2023. 709 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

  • Penserra Capital Management reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
  • Penserra Capital Management sold 20,160 Sanofi shares in Q4 2023, an estimated $1.08M.
  • Penserra Capital Management first reported a position in Sanofi in Q3 2022 and held it in 5 quarters.
  • Penserra Capital Management's Sanofi position peaked at $1.08M in Q3 2023.
  • 709 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Penserra Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.